Sandoz Group AG (SDZNY)
OTCMKTS · Delayed Price · Currency is USD
85.53
-0.82 (-0.94%)
Feb 23, 2026, 3:52 PM EST
Sandoz Group AG Revenue
Sandoz Group AG had revenue of $5.27B in the half year ending June 30, 2025, with 6.80% growth. This brings the company's revenue in the last twelve months to $10.59B, up 4.71% year-over-year. In the year 2024, Sandoz Group AG had annual revenue of $10.38B with 4.06% growth.
Revenue (ttm)
10.59B
Revenue Growth
+4.71%
P/S Ratio
3.52
Revenue / Employee
529.35K
Employees
20,000
Market Cap
37.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10.38B | 405.00M | 4.06% |
| Dec 31, 2023 | 9.98B | 673.00M | 7.23% |
| Dec 31, 2022 | 9.31B | -372.00M | -3.84% |
| Dec 31, 2021 | 9.68B | 20.00M | 0.21% |
| Dec 31, 2020 | 9.66B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sofgen Pharma | 423.75M |
| Jushi Holdings | 260.43M |
| Glass House Brands | 196.17M |
| MariMed | 157.38M |
| Elite Pharmaceuticals | 140.12M |
| Earth Science Tech | 34.87M |
| Radnostix | 14.07M |
| Healthy Extracts | 3.59M |
Sandoz Group AG News
- 5 days ago - Sandoz wins FDA nod to expand Enzeevu label to multiple retinal indications - Seeking Alpha
- 18 days ago - Sandoz: The Share Price May Have Run Its Course - Seeking Alpha
- 5 weeks ago - Sandoz Secures European Commission Approval For Ondibta, A Biosimilar To Lantus, For Diabetes - Nasdaq
- 5 weeks ago - Sandoz Group AG (SDZNY) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow - Seeking Alpha
- 5 weeks ago - Sandoz Group AG at JPMorgan Healthcare Conference Transcript - GuruFocus
- 5 weeks ago - Sandoz Group AG (SDZNY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - SDZNY vs. STVN: Which Stock Is the Better Value Option? - Nasdaq
- 2 months ago - Zacks Industry Outlook Highlights Sandoz, Teva Pharmaceuticals and Dr. Reddy's - Nasdaq